Real time Form 13D and 13G transaction reports:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
| Reported DateTime | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | Filing |
| 2024-09-06 08:31 am Purchase | 13D | GYRE THERAPEUTICS INC GYRE | Ma Songjiang | 7,456,847 7.620% | 7,456,847 (New Position) | View |
| 2024-09-06 08:15 am Purchase | 13D | GYRE THERAPEUTICS INC GYRE | Luo Ying | 8,458,983 8.540% | 8,458,983 (New Position) | View |
| 2024-02-14 1:18 pm Unchanged | 13G | GYRE THERAPEUTICS INC GYRE | LYTTON LAURENCE W | 0 0.000% | 0 (Unchanged) | View |
| 2024-01-24 5:11 pm Unchanged | 13D | GYRE THERAPEUTICS INC GYRE | GNI Group Ltd. | 73,313,885 85.340% | 0 (Unchanged) | View |
| 2023-11-27 4:49 pm Unchanged | 13D | GYRE THERAPEUTICS INC GYRE | GNI Group Ltd. | 73,313,885 85.360% | 0 (Unchanged) | View |
| 2023-11-01 4:58 pm Purchase | 13D | GYRE THERAPEUTICS INC GYRE | GNI Group Ltd. | 73,313,885 85.360% | 73,313,885 (New Position) | View |
| 2023-10-30 7:28 pm Unchanged | 13D | GYRE THERAPEUTICS INC GYRE | GNI Group Ltd. | 6,266,521 16.500% | 0 (Unchanged) | View |
| 2023-02-14 4:46 pm Sale | 13G | GYRE THERAPEUTICS INC GYRE | Nantahala Capital Management LLC | 438,055 1.400% | -2,323,605 (-84.14%) | View |
| 2023-02-14 4:09 pm Sale | 13G | GYRE THERAPEUTICS INC GYRE | ORBIMED ADVISORS LLC | 0 0.000% | -1,350,602 (Position Closed) | View |
| 2023-02-13 2:55 pm Purchase | 13G | GYRE THERAPEUTICS INC GYRE | LYTTON LAURENCE W | 2,667,333 7.100% | 803,218 (+43.09%) | View |
| 2023-02-13 12:06 pm Sale | 13G | GYRE THERAPEUTICS INC GYRE | RENAISSANCE TECHNOLOGIES LLC | 1,186,986 3.140% | -584,922 (-33.01%) | View |
| 2023-01-04 6:13 pm Purchase | 13D | GYRE THERAPEUTICS INC GYRE | GNI Group Ltd. | 6,266,521 16.600% | 6,266,521 (New Position) | View |
| 2022-10-07 07:45 am Sale | 13D | GYRE THERAPEUTICS INC GYRE | SINGER JULIAN D. | 1,082,400 3.440% | -1,165,042 (-51.84%) | View |
| 2022-09-22 4:15 pm Sale | 13D | GYRE THERAPEUTICS INC GYRE | JEC II Associates LLC | 0 0.000% | -2,505,000 (Position Closed) | View |
| 2022-08-19 4:30 pm Unchanged | 13D | GYRE THERAPEUTICS INC GYRE | SINGER JULIAN D. | 2,247,442 7.100% | 0 (Unchanged) | View |
| 2022-08-03 4:17 pm Unchanged | 13D | GYRE THERAPEUTICS INC GYRE | SINGER JULIAN D. | 2,247,442 7.100% | 0 (Unchanged) | View |
| 2022-08-01 4:15 pm Unchanged | 13D | GYRE THERAPEUTICS INC GYRE | JEC II Associates LLC | 2,505,000 8.000% | 0 (Unchanged) | View |
| 2022-07-22 2:21 pm Purchase | 13D | GYRE THERAPEUTICS INC GYRE | SINGER JULIAN D. | 2,247,442 7.100% | 232,610 (+11.54%) | View |
| 2022-07-01 4:15 pm Unchanged | 13D | GYRE THERAPEUTICS INC GYRE | JEC II Associates LLC | 2,505,000 8.000% | 0 (Unchanged) | View |
| 2022-06-21 5:02 pm Purchase | 13D | GYRE THERAPEUTICS INC GYRE | JEC II Associates LLC | 2,505,000 8.000% | 2,505,000 (New Position) | View |